Microbot Medical Inc (NASDAQ:MBOT) price closed higher on Monday, June 30, and jumping 0.80% above its previous close.
A look at the daily price movement shows that the last close reads $2.5, with intraday deals fluctuated between $2.49 and $2.6. The company’s 5Y monthly beta was ticking 1.145. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.38 and 52-week low of $0.82. The stock subtracted -5.97% on its value in the past month.
Microbot Medical Inc, which has a market valuation of $91.67 million, is expected to release its quarterly earnings report on 2025-May-14.
Staying with the analyst view, there is a consensus estimate of 3M for the company’s annual revenue in current year.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give MBOT a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 75% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned MBOT a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Microbot Medical Inc (MBOT) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that MBOT’s price is at present -0.38% off the SMA20 and -0.17% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 51.13, with weekly volatility standing at 4.61%. The indicator jumps to 5.61% when calculated based on the past 30 days. Microbot Medical Inc (NASDAQ:MBOT)’s beta value is holding at 1.13.
An analysis of the Microbot Medical Inc (NASDAQ:MBOT) stock in terms of its daily trading volume indicates that the 3-month average is 2.57 million. However, this figure increases on the past 10-day timeline to an average of 0.92 million.
Current records show that the company has 36.38M in outstanding shares. The insiders’ percentage holdings are 1.09% of outstanding shares while the percentage share held by institutions stands at 11.05%. The stats also highlight that short interest as of 2025-06-13, stood at 8.06 million shares, which puts the short ratio at the time at 4.25. From this we can glean that short interest is 2239.00 of company’s current outstanding shares. Notably, we see that shares short in June rose slightly given the previous month’s figure stood at 6.78 million. But the 152.00% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
